Researchers Work Around Hepatitis Drug Patent
Several readers let us know about a pair of British researchers who found a workaround to patents covering drugs used to treat hepatitis C. The developers intend to produce a drug cheap enough to supply to people in the poorest parts of the world. The scientists found another way to bind a sugar to interferon, producing a drug they say should be as long-lasting and effective as those sold (at $14,000 for a year's supply) by patent holders Hoffman-La Roche and Schering Plough. Clinical trials could begin by 2008. The article quotes developer Sunil Shaunak of Imperial College London: "We in academic medicine can either choose to use our ideas to make large sums of money for small numbers of people, or to look outwards to the global community and make affordable medicines."
... just vehicles to ensure progress.
there is no such thing as a "natural right" an inventor has: patent law builds on the premise that a patent is a reward and that many people like to be rewarded.
you are confusing it with copyright law - which grants the author rights because it is his creation - no one else could habe written harry potter, for example. in contrast, sooner or later someone figures out how molecule XYZ can be synthesized - there usually is no "personal creativity" involved.
The relevant bit:
[1] An earlier bit mentions the oath taker's "parents." These are to be understood to be his mentors. Thus "his children" are the oath taker's peers.
After all, I am strangely colored.